IL1B and chronic recurrent multifocal osteomyelitis: This led to the identification of Interleukin (IL)-1β and its receptor as key drivers of bone lesions in CRMO, highlighting the “redundant” role for NLRP3 (NLR family pyrin domain containing 3)/caspase-1 and caspase-8.